Annual report pursuant to Section 13 and 15(d)

Net Loss per Common Share (Schedule of Diluted Weighted Average Shares Outstanding) (Details)

v3.23.1
Net Loss per Common Share (Schedule of Diluted Weighted Average Shares Outstanding) (Details) - shares
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Potentially dilutive securities excluded from the computations of diluted weighted average shares outstanding 22,634,754 21,904,246
Warrants to Purchase Common Stock [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Potentially dilutive securities excluded from the computations of diluted weighted average shares outstanding 3,495,870 4,528,196
Options to Purchase Common Stock [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Potentially dilutive securities excluded from the computations of diluted weighted average shares outstanding 724,757 832,134
Unvested Restricted Stock [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Potentially dilutive securities excluded from the computations of diluted weighted average shares outstanding 18,375,001 16,363,068
Unvested Restricted Stock Units [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Potentially dilutive securities excluded from the computations of diluted weighted average shares outstanding 39,125 180,848